Octamoxin

Octamoxin (trade names Ximaol, Nimaol), also known as 2-octylhydrazine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class that was used as an antidepressant in the 1960s but is now no longer marketed.[2][3][4][5]

Octamoxin

Names
Preferred IUPAC name 1-Methylheptylhydrazine
Systematic IUPAC name Octan-2-ylhydrazine[1]
Identifiers
CAS Number	4684-87-1
3D model (JSmol)	Interactive image
ChemSpider	19587
PubChem CID	20811
UNII	0HXY3M6S54
InChI InChI=1S/C8H20N2/c1-3-4-5-6-7-8(2)10-9/h8,10H,3-7,9H2,1-2H3 Key: FODQIVGFADUBKE-UHFFFAOYSA-N
SMILES CCCCCCC(C)NN
Properties
Chemical formula	C8H20N2
Molar mass	144.262 g·mol^−1
Density	0.831 g/mL
Boiling point	228 °C (442 °F; 501 K)
Pharmacology
Routes of administration	Oral
Related compounds
Related compounds	Tuaminoheptane
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

See also

• Hydrazine (antidepressant)

References

1. "Octamoxin - Compound Summary". USA: National Center for Biotechnology Information. 26 March 2005. Identification and Related Records. Retrieved 31 May 2012.
2. Ganellin, C. R.; Triggle, David J. (21 November 1996). Dictionary of pharmacological agents - Google Books. ISBN 9780412466304.
3. "13-06781. Octamoxin [Archived]: The Merck Index".
4. Levy J, Michel-Ber E (1966). "[Relations between the antidepressive effects of octamoxine revealed by 3 pharmacological tests and inhibition of cerebral monoamine oxidase in mice]". Thérapie (in French). 21 (4): 929–45. PMID 5925088.
5. Gayral L, Stern H, Puyuelo R (1966). "[Indications and results of the treatment of mental depression by octamoxine (ximaol)]". Thérapie (in French). 21 (5): 1183–90. PMID 5976767.